Connor Landgraf, Tyler Crouch, Jason Bellet
Eko is elevating the way clinicians detect and monitor cardiac and respiratory disease by bringing together advanced sensors, patient and provider software, and AI-powered analysis. Its FDA-cleared device has been purchased by over 55,000 clinicians treating millions of patients in over 25 countries, in-person and through telehealth.
“The NTTVC team has been hands-on from day one, taking the time to fully understand and align with our vision.
They have been instrumental in building our executive talent bench and helping us scale the business more quickly than we thought possible.”